Diabetes Care Devices Market Size By Product (Blood Glucose Monitoring Devices {Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets}, Insulin Delivery Devices {Insulin Pumps [Tubed Pumps, Tubeless Pumps], Pen [Reusable, Disposable], Pen Needles [Standard, Safety], Syringes}), By End-Use (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers, Home Care) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Apr 2019  |  Report ID: GMI3250  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 260   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Diabetes Care Devices Market size valued at around USD 28 billion in 2018 and is expected to grow at 5.9% CAGR between 2019 and 2025. Increasing efforts by the government of various countries such as the U.S., Australia, Canada to incentivize and support diabetes care will positively influence the market revenue.
 

Diabetes Care Devices Market

Get more details on this report - Request Free Sample PDF
 

Growing prevalence of diabetes across the world will significantly contribute to the global market demand. As per the International Diabetes Federation, about 425 million adults aged between 20 to 79 years of age were living with diabetes in 2017 and the number is estimated to escalate to 629 million by 2045. Rising prevalence and incidence of diabetes will accelerate the adoption of glucose monitoring as well as insulin delivery devices for better care and management of the disease, thus highly impacting the market growth trends.
 

Availability of reimbursement policies and insurance will boost the diabetes care devices market share. Reimbursements and insurance policies support the adoption and usage of diabetes care devices by diabetic patients. However, limited reimbursement for some diabetes care devices such as continuous glucose monitors and insulin pumps in few countries may restrain the industry growth.
 

Diabetes Care Devices Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 27.9 Billion (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 5.9% 2025 Value Projection: 41.5 Billion (USD)
Pages: 260 Tables, Charts & Figures: 367
Geographies covered (24): U.S., Canada, Germany, France, UK, The Netherlands, Sweden, Belgium, Denmark, Finland, Norway, Lithuania, Latvia, Estonia, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia
Segments covered: Products, End-Use and Region
Companies covered (21): Abbott Laboratories, Arkray, Inc., B. Braun Melsungen AG, Bayer Corporation, Dexcom Inc., F. Hoffmann-La Roche Ag, Johnson & Johnson (LifeScan, Inc.), Medtronic PLC, Sinocare, Inc., Nova Biomedical, Inc., Becton Dickinson and Company, Sanofi, Eli Lilly and Company, Insulet Corporation, Novo Nordisk, Wockhardt Limited, Ypsomed Holding AG, Companion Medical, Bespak (Consort Medical subsidiary), Valeritas Holdings Inc., West Pharmaceutical Services, Inc.
Growth Drivers:
  • Growing prevalence of diabetes
  • Technological advancements in the field of diabetes
  • Favorable device insurance and reimbursement policies
  • Increased government initiatives for better awareness
Pitfalls & Challenges:
  • Low per capita expenditure on diabetes
  • Lack of reimbursement and stringent regulations in few countries

Get more details on this report - Request Free Sample PDF
 

Market, By Product

U.S. Diabetes Care Devices Market By Product

Get more details on this report - Request Free Sample PDF
 

Blood glucose monitoring devices revenue exceeded USD 16.9 billion in 2018. Growing acceptance of blood glucose monitoring devices for diabetes care will largely impact adoption of such devices. Also, increasing number of admissions in healthcare facilities will result into greater adoption of blood glucose monitoring devices to prevent complications related to high blood sugar levels. With increasing incidence of diabetes, the need to monitor blood glucose continuously as well as the demand for self-monitoring of blood glucose will spur over the coming years.
 

Insulin delivery devices product segment is estimated to witness over 6.1% growth rate during the forecast timeframe. Insulin delivery devices are witnessing various technological advancements for better and efficient delivery of insulin. Novel insulin delivery devices include wearable drug delivery devices. Adoption for such devices will thus increase due to improved drug delivery and glucose control. Moreover, the demand for insulin pens among other insulin delivery devices is predicted to grow at a rapid pace owing to easy application, greater accuracy, and high convenience.
 

Market, By End-use

India Diabetes Care Devices Market By End-use

Get more details on this report - Request Free Sample PDF
 

Hospitals end-use segment accounted for the largest diabetes care devices market share of 45% in 2018. Growing hospitalization increases the need to accurately measure and control blood glucose, thereby avoiding morbidity, complications, and mortality. Growing chronic disease prevalence, especially diabetes, will increase the demand for diabetes care devices in hospitals. In addition, availability of portable and advanced devices for diabetes care in hospitals will impact the segment share.
 

Home care diabetes end-use segment is predicted to expand at 6.4% CAGR through 2025. There is an increasing adoption of blood sugar monitoring and insulin delivery devices in home care settings. High convenience, remote monitoring, portability along with considerable precision are the major factors for robust segment growth. Self-monitoring of blood sugar and control of blood glucose at home facilitates enhanced care and maintenance of diabetes with greater affordability.
 

Market, By Region

U.S. diabetes care devices market dominated around 91% revenue share in 2018 and is poised to exceed USD 14.5 billion by 2025 owing to rising population suffering from diabetes as well as increasing expenditure on diabetes care per person. Moreover, technological advancements coupled with approval of new products for diabetes monitoring and control in the country will propel the United States market expansion.
 

Germany market value was over USD 2.2 billion in 2018. High prevalence of diabetes is witnessed in Germany due to increasing adoption of sedentary lifestyle, unhealthy eating habits and growing obesity prevalence. Also, the German healthcare system provides reimbursement and insurance for majority of diabetes care devices that should boost the customer adoption rate for the products in the country. Additionally, high adoption of insulin delivery devices and increasing per capita spending on diabetes will spur the German industry revenue.
 

Competitive Market Share

Major organizations operating in the industry include Abbott Laboratories, Johnson & Johnson (LifeScan, Inc.), Medtronic plc, Becton Dickinson and Company, and Eli Lilly & Company. Firms are adopting new product development and strategic partnerships to earn higher profits in the market.
 

The diabetes care devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:
 

Market, by Product

  • Blood glucose monitoring devices
    • Self-monitoring blood glucose meters
    • Continuous glucose monitors
    • Testing strips
    • Lancets
  • Insulin delivery devices
    • Insulin pumps
      • Tubed pumps
      • Tubeless pumps
    • Pens
      • Reusable pens
      • Disposable pens
    • Pen needles
      • Standard pen needles
      • Safety pen needles
    • Syringes
    • Others

Market, by End-use

  • Hospitals
  • Ambulatory surgery centers
  • Diagnostic centers
  • Home care
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • The Netherlands
    • Sweden
    • Belgium
    • Denmark
    • Finland
    • Norway
    • Lithuania
    • Latvia
    • Estonia
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Others
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Others

 

Frequently Asked Questions (FAQ) :

The market size of diabetes care devices Market valued at around USD 28 billion in 2018.
The industry share of diabetes care devices is expected to grow at 5.9% CAGR between 2019 and 2025.
U.S. market dominated around 91% revenue share in 2018 and is poised to exceed USD 14.5 billion by 2025 owing to rising population suffering from diabetes as well as increasing expenditure on diabetes care per person.
According to the analyst at GMI, the insulin delivery devices product segment is estimated to witness over 6.1% growth rate during the forecast timeframe.
Major organizations operating in the industry include Abbott Laboratories, Johnson & Johnson (LifeScan, Inc.), Medtronic plc, Becton Dickinson and Company, and Eli Lilly & Company.
Stakeholders are focusing on blood glucose monitoring devices due to the notable uptick in the number admissions in healthcare facilities and rising need for self-monitoring of blood glucose.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Apr 2019
  • Pages: 260
  • Tables: 360
  • Charts / Figures: 7
  • Companies covered: 21
  • Countries covered: 24

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X